CB Insights
Technology Market Intelligence
Technology Market Intelligence
Alector is a neurology-focused startup that is focused on the discovery and development of immuno-modulatory therapies for Alzheimer's disease and other neurodegenerative disorders. The company is combining antibody technology and recent discoveries ...Show all
Company (IPO / Went public)
Phone: 415-231-5660
151 Oyster Blvd
Suite 300
South San Francisco, 94080
California, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Chimeric receptors and methods of use thereof | Apr 26, 2017 | Dec 29, 2020 | Patent |
| Methods of screening for sortilin binding antagonists | Apr 07, 2016 | Dec 01, 2020 | Patent |
| Anti-siglec-9 antibodies and methods of use thereof | Oct 28, 2016 | Oct 13, 2020 | Patent |
| Anti-cd33 antibodies and methods of use thereof | Aug 03, 2018 | Jul 14, 2020 | Patent |
| Anti-trem2 antibodies and methods of use thereof | Aug 03, 2018 | Jun 09, 2020 | Patent |
